ATE476195T1 - Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung - Google Patents

Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung

Info

Publication number: ATE476195T1
Authority: AT; Austria
Prior art keywords: composition; peptide; insulin; pro; gel
Prior art date: 2005-06-02

Application number

AT06744056T

Other languages

English (en)

Inventor

John Wahren

Anders Carlsson

Original Assignee

Cebix Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-02

Filing date

2006-06-02

Publication date

2010-08-15

2006-06-02 Application filed by Cebix Inc filed Critical Cebix Inc

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE476195T1 publication Critical patent/ATE476195T1/de

Links

VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 title abstract 3
108010075254 C-Peptide Proteins 0.000 title abstract 3
238000002360 preparation method Methods 0.000 title abstract 2
230000003111 delayed effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 abstract 6
230000015572 biosynthetic process Effects 0.000 abstract 1
229910021645 metal ion Inorganic materials 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT06744056T 2005-06-02 2006-06-02 Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung ATE476195T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0511269.3A GB0511269D0 (en)	2005-06-02	2005-06-02	Sustained release preparation of pro-insulin C-peptide
PCT/GB2006/001997 WO2006129095A2 (en)	2005-06-02	2006-06-02	Sustained release preparations of pro-insulin c-peptide

Publications (1)

Publication Number	Publication Date
ATE476195T1 true ATE476195T1 (de)	2010-08-15

Family

ID=34835031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06744056T ATE476195T1 (de)	2005-06-02	2006-06-02	Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung

Country Status (6)

Country	Link
US (1)	US8927489B2 (de)
EP (1)	EP1912669B1 (de)
AT (1)	ATE476195T1 (de)
DE (1)	DE602006015968D1 (de)
GB (1)	GB0511269D0 (de)
WO (1)	WO2006129095A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0511269D0 (en)	2005-06-02	2005-07-13	Creative Peptides Sweden Ab	Sustained release preparation of pro-insulin C-peptide
WO2008118390A2 (en) *	2007-03-23	2008-10-02	Wayne State University	Biomarkers for diagnostic and therapeutic methods
WO2008118387A2 (en) *	2007-03-23	2008-10-02	Wayne State University	Erythrocyte atp-release modulators
WO2011081915A2 (en) *	2009-12-15	2011-07-07	Cebix Inc.	Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
CA2798518A1 (en)	2010-05-17	2011-11-24	Cebix, Inc.	Pegylated c-peptide
ES2673672T3 (es)	2011-02-11	2018-06-25	The Regents Of The University Of Michigan	Composiciones tripeptídicas y su uso para el tratamiento de la diabetes

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2143590A (en)	1936-09-26	1939-01-10	Univ Alberta	Insulin preparation and process of producing crystals of insulin
US2882203A (en)	1951-06-26	1959-04-14	Novo Terapeutisk Labor As	Injectable insulin preparation with protracted effect
NL289055A (de)	1963-02-15
US3852422A (en)	1971-06-26	1974-12-03	Serono Ist Farm	Long-active gonadotropins
BE795516A (fr) *	1972-02-17	1973-08-16	Ciba Geigy	Preparations de peptides huileuses et injectables et procede pour leur preparation
CH650679A5 (de)	1981-08-27	1985-08-15	Lilly Co Eli	Gegen diabetes mellitus wirksames pharmazeutisches mittel.
HU196714B (en)	1984-10-04	1989-01-30	Monsanto Co	Process for producing non-aqueous composition comprising somatotropin
GB9108634D0 (en)	1991-04-23	1991-06-12	Ciba Geigy	Pharmaceutical compositions
NZ250844A (en)	1993-04-07	1996-03-26	Pfizer	Treatment of non-insulin dependant diabetes with peptides; composition
WO1995021622A1 (en)	1994-02-09	1995-08-17	Brigham & Women's Hospital	Gel-forming polypeptide derivatives
US5595760A (en)	1994-09-02	1997-01-21	Delab	Sustained release of peptides from pharmaceutical compositions
EP0796106B1 (de)	1994-12-23	2003-03-19	Novo Nordisk A/S	Glp-1 zusammensetzungen mit verlängerter wirkdauer
US20010007673A1 (en) *	1999-11-12	2001-07-12	Merrill Seymour Goldenberg	Sustained-release delayed gels
FR2776520B1 (fr)	1998-03-25	2000-05-05	Sod Conseils Rech Applic	Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
DE10041478A1 (de) *	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
DE10055857A1 (de) *	2000-11-10	2002-08-22	Creative Peptides Sweden Ab Dj	Neue pharmazeutische Depotformulierung
GB0117057D0 (en)	2001-07-12	2001-09-05	Ferring Bv	Pharmaceutical composition
US7098305B2 (en)	2001-09-06	2006-08-29	Ardana Bioscience Limited	Sustained release of microcrystalline peptide suspensions
ATE432689T1 (de)	2002-03-04	2009-06-15	Ipsen Pharma	Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
GB0218970D0 (en)	2002-08-14	2002-09-25	Creative Peptides Sweden Ab	Fragments of Insulin c-peptide
US7884185B2 (en) *	2004-07-28	2011-02-08	University Of Delaware	Hydrogels and uses thereof
US20060046962A1 (en) *	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
GB0511269D0 (en)	2005-06-02	2005-07-13	Creative Peptides Sweden Ab	Sustained release preparation of pro-insulin C-peptide
CA2798518A1 (en) *	2010-05-17	2011-11-24	Cebix, Inc.	Pegylated c-peptide

2005
- 2005-06-02 GB GBGB0511269.3A patent/GB0511269D0/en not_active Ceased
2006
- 2006-06-02 AT AT06744056T patent/ATE476195T1/de not_active IP Right Cessation
- 2006-06-02 US US11/916,116 patent/US8927489B2/en not_active Expired - Fee Related
- 2006-06-02 EP EP06744056A patent/EP1912669B1/de not_active Not-in-force
- 2006-06-02 DE DE602006015968T patent/DE602006015968D1/de active Active
- 2006-06-02 WO PCT/GB2006/001997 patent/WO2006129095A2/en not_active Ceased

Also Published As

Publication number	Publication date
US20090170761A1 (en)	2009-07-02
WO2006129095A3 (en)	2007-05-10
DE602006015968D1 (de)	2010-09-16
US8927489B2 (en)	2015-01-06
WO2006129095A2 (en)	2006-12-07
EP1912669A2 (de)	2008-04-23
GB0511269D0 (en)	2005-07-13
EP1912669B1 (de)	2010-08-04

Legal Events

Date	Code	Title	Description
2011-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
MY143795A (en)	2011-07-15	Tetrahydropyridoindole derivatives
AU2003275958A1 (en)	2005-03-10	Muteins of tear lipocalin
SG145712A1 (en)	2008-09-29	Crystalline tumor necrosis factor receptor 2 polypeptides
EP1670450B8 (de)	2011-03-23	Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2010006370A (es)	2010-06-30	Composiciones de activo antitranspirante que tienen un cromatograma sec que exhibe una intensidad de pico 4 sec elevada.
WO2003053368A3 (en)	2003-09-18	Chalcone derivatives and their use to treat diseases
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
GEP20074211B (en)	2007-10-10	Novel perindopril salt and pharmaceutical compositions containing same
EP1423137A4 (de)	2005-11-30	Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
WO2007076085A3 (en)	2007-08-23	Fused pyrimidones and thiopyrimidones, and uses thereof
WO2007092343A3 (en)	2008-01-17	Novel epoprostenol formulation and method of making thereof
ZA200408410B (en)	2005-12-28	Pesticidal pyridinecarboxamide derivatives
CO5660287A2 (es)	2006-07-31	Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200702589A1 (ru)	2008-06-30	2,6-хинолинильные производные, способы их получения и их применение
WO2007064968A3 (en)	2007-12-27	Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
ATE476195T1 (de)	2010-08-15	Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung
IL183779A0 (en)	2007-09-20	Vitamin d receptor modulators
WO2007076087A3 (en)	2007-11-08	3-aryl-substituted quinazolones, and uses thereof
SE0300457D0 (sv)	2003-02-19	Novel compounds
YU38103A (sh)	2006-05-25	Nova jedinjenja askorbinske kiseline, postupci sinteze i način njihove primene
TW200613279A (en)	2006-05-01	New pesticides
MX2007011826A (es)	2007-11-22	Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.
DK1699468T3 (da)	2007-09-03	Farmaceutisk sammensætning, der omfatter et zink-hyaluronatkompleks, til behandling af dissemineret skelrose